Evidence map›Paper›PMID 38924791›Full record

ArticleJournal of the National Cancer Institute. Monographs2024

National Cancer Institute-funded grants focused on synchronous telehealth cancer care delivery: a portfolio analysis.

Roxanne E Jensen, Rachelle Brick, Joshua Medel, Priyanga Tuovinen, Paul B Jacobsen, Rebecca Hardesty, Robin C Vanderpool

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute. Monographs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roxanne E JensenDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-4632-1091
Rachelle BrickDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0001-7099-7799
Joshua MedelDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
Priyanga TuovinenDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0001-9129-6078
Paul B JacobsenDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-4427-8800
Rebecca HardestyDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0009-0000-3223-3835
Robin C VanderpoolDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0001-9995-4485

Funding

HHSNCI NIH HHSNIH HHS
6 · The paper itself

Abstract

backgroundTelehealth use increased during the COVID-19 pandemic and remains a complementary source of cancer care delivery. Understanding research funding trends in cancer-related telehealth can highlight developments in this area of science and identify future opportunities.

methodsApplications funded by the US National Cancer Institute (NCI) between fiscal years 2016 and 2022 and focused on synchronous patient-provider telehealth were analyzed for grant characteristics (eg, funding mechanism), cancer focus (eg, cancer type), and study features (eg, type of telehealth service). Of 106 grants identified initially, 60 were retained for coding after applying exclusion criteria.

resultsAlmost three-quarters (73%) of telehealth grants were funded during fiscal years 2020-2022. Approximately 67% were funded through R01 or R37 mechanism and implemented as randomized controlled trials (63%). Overall, telehealth grants commonly focused on treatment (30%) and survivorship (43%); breast cancer (12%), hematologic malignancies (10%), and multiple cancer sites (27%); and health disparity populations (ie, minorities, rural residents) (73%). Both audio and video telehealth were common (65%), as well as accompanying mHealth apps (20%). Telehealth services centered on psychosocial care, self-management, and supportive care (88%); interventions were commonly delivered by mental health professionals (30%).

conclusionNCI has observed an increase in funded synchronous patient-provider telehealth grants. Trends indicate an evolution of awards that have expanded across the cancer control continuum, applied rigorous study designs, incorporated additional digital technologies, and focused on populations recognized for disparate cancer outcomes. As telehealth is integrated into routine cancer care delivery, additional research evidence will be needed to inform clinical practice.

Indexed as

COVID-19National Cancer Institute (U.S.)NeoplasmsTelemedicineDelivery of Health CareFinancing, OrganizedHumansSARS-CoV-2United States

Identifiers

PMID38924791
PMCPMC11207831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.